Sunil Bhonsle | President and CEO |
Dr. Marc Rubin | Executive Chairman |
Dr. Kate DeVarney | EVP and Chief Scientific Officer |
Dane Hallberg | EVP and Chief Commercial Officer |
Brian Crowley | VP, Finance and Administration |
Jennifer Kiernan | Executive Assistant to CEO and Investor Communications Coordinator |
Anita Dushyanth | Zacks Investment Research |
Thank you for holding and welcome to the Titan Pharmaceuticals Fourth Quarter and Full Year 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session following today's remarks. Please be advised that this call is being taped at the Company's request and will be archived on the Company's website, starting later today.
At this time, I would like to turn the conference over to Sunil Bhonsle, President and CEO of Titan Pharmaceuticals.